tiprankstipranks
Trending News
More News >
Caris Life Sciences, Inc. (CAI)
NASDAQ:CAI
US Market

Caris Life Sciences, Inc. (CAI) Income Statement

Compare
126 Followers

Caris Life Sciences, Inc. Income Statement

Last quarter (Q3 2025), Caris Life Sciences, Inc.'s total revenue was $216.83M, an increase of 153.03% from the same quarter last year. In Q3, Caris Life Sciences, Inc.'s net income was $24.32M. See Caris Life Sciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 20Dec 19
Total Revenue
$ 412.26M$ 306.13M$ 258.49M$ 294.01M$ 416.54M
Gross Profit
$ 178.78M$ 89.31M$ 80.02M$ 184.16M$ 200.51M
Operating Expenses
$ 435.90M$ 408.86M$ 395.78M$ 45.07M$ 70.23M
Depreciation and Amortization
$ 48.91M$ 49.00M$ 48.25M$ 110.65M$ 113.93M
EBITDA
$ -182.95M$ -260.80M$ -245.89M$ 254.46M$ 248.30M
Operating Income
$ -257.12M$ -319.55M$ -315.76M$ 139.09M$ 130.28M
Other Income/Expenses
$ -24.77M$ -21.86M$ -5.07M$ -109.55M$ 0.00
Pretax Income
$ -281.89M$ -341.42M$ -320.83M$ 29.53M$ 55.21M
Net Income
$ -281.89M$ -341.42M$ -320.83M$ 27.73M$ 31.01M
Per Share Metrics
Basic EPS
$ -2.70$ -1.82$ -1.57$ 1.55$ 1.72
Diluted EPS
$ -2.70$ -1.82$ -1.57$ 1.55$ 1.72
Weighted Average Shares Outstanding
254.66M 254.66M 254.79M 17.95M 18.01M
Weighted Average Shares Outstanding (Diluted)
254.66M 254.66M 254.79M 17.95M 18.01M
Currency in USD

Caris Life Sciences, Inc. Earnings and Revenue History